Mrna Vaccines Therapeutics 2022 pdf for Curia

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners turn their ideas into real-world impact. We partner closely with pharmaceutical and biotechnology companies to boost business performance and improve patients’ lives. From early discovery and development through manufacturing and commercialization, ou...
Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners turn their ideas into real-world impact. We partner closely with pharmaceutical and biotechnology companies to boost business performance and improve patients’ lives. From early discovery and development through manufacturing and commercialization, our suite of custom solutions allows us to tailor every engagement to your precise needs, whether that’s an independent project or an opportunity that cuts across the drug continuum.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
26 Corporate Circle, Albany, New York 12203
Telephone
Telephone
+1 518.512.2000

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

CPhI Worldwide, Milan

CPhI Worldwide, Milan

Not Confirmed

envelop Contact Supplier

CPhI Worldwide, Milan

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
“We’re unlocking life-changing potential in complex molecules, without sacrificing time to market”
This week, SpeakPharma interviews Mike Riley, CEO of Veranova, a leading contract development and manufacturing organization (CDMO) confidently mastering complex APIs as it marks its second year as an independent company. Riley discusses Veranova’s key achievements, including a US$ 30 million investment in their Devens, Massachusetts (US) site to expand capabilities in antibody-drug conjugates (ADCs) and highly potent APIs (HPAPIs), and how it is navigating the increasing complexity of molecules. 🔑 HIGHLIGHTS// Veranova’s key achievements / navigating the increasing complexity of molecules Veranova is celebrating its second year as a stand-alone company. Can you share Veranova’s key milestones and achievements in its first two years? We have achieved incredible milestones over the last two years, thanks to the dedication and hard work of our team. Our first 12 months focused on establishing ourselves as an independent CDMO by building on the 50 years of expertise that we brought with us. In addition, we expanded our capabilities and applied a more agile approach available to us as a company singularly focused on life sciences. This has allowed us to move into our second year with clear and strategic goals for generating growth in our sites, people, capabilities, and offerings. Since being appointed as CEO in May 2023, I’ve had the pleasure of witnessing some exciting growth milestones of my own. Most recently, we announced an estimated US$ 30 million investment in our Devens, Massachusetts, site. This expansion will allow us to build upon existing development and manufacturing capabilities in ADCs and HPAPIs that will address the growing demand for strong US-based capacity in these key drug modalities. We also appointed our Advisory Board, thereby bolstering Veranova’s in-house expertise. Made up of four distinguished leaders in pharma and biopharma – including Dr. Carolyn Bertozzi, the 2022 Nobel Laureate in Chemistry – the Board has provided thought-leadership, guidance and expertise as we develop and execute our strategic growth and ideas. We were also proud to be recognized as one of the Society of Chemical Manufacturers and Affiliates’ 12 companies for industry-leading safety programs in 2023 and as a part of the Medicine Maker’s Power List in 2024. 🔑 HIGHLIGHTS// US$ 30 million investment in our Devens, Massachusetts, site / appointed our Advisory Board Molecules are becoming increasingly complex. Can you elaborate on how Veranova’s current capabilities are strategically designed to address this trend in the coming years? The pharmaceutical pipeline is witnessing an increasing number of complex and highly potent molecules. This trend is driven by the demand for more targeted, patient-centric therapeutics and the focus on innovative modalities such as ADCs and other bioconjugates. At Veranova, our expertise, world-class facilities, and scientific excellence enable us to provide our customers with the clarity and solutions needed to manage this development and manufacturing complexity and ultimately deliver the required treatments to customers and patients. Our people are key to this approach. We have an expert team ready to collaborate with customers at any point, from early development through large-scale commercial production. Our services include world-leading crystallization development, process development, and specialized manufacturing expertise for complex synthetic molecules, including those requiring chromatography capabilities. In many cases, we can provide all these under one roof. Our service offering to our customers is also based on the foundational element of strong quality and compliance systems. We operate multiple facilities approved by the US FDA, UK’s MHRA and other regulatory authorities and are continually focused on ways to strengthen our global quality management system. Looking ahead, we are focused on continually investing in our facilities and team to meet growing complexity, as evidenced by our recent announcement of new investment in our Devens site. This investment signals our commitment to providing state-of-the-art capacity and capabilities to enable these next-generation therapies to reach patients. It is a key milestone as we advance Veranova’s broader growth strategy. 🔑 HIGHLIGHTS// provide our customers with clarity and solutions / world-leading crystallization development / expertise for complex synthetic molecules / strong quality and compliance systems How is Veranova approaching the challenge of designing and manufacturing effective linker molecules for ADCs? As a leader in complex linker-payload synthesis, Veranova is committed to unlocking the life-changing potential of ADCs without letting their complexities slow down the development of much-needed cancer therapies. ADCs are intricate, multi-component molecules that require extensive expertise and agile collaboration to overcome unique development challenges. With over a decade of experience in ADC linker-payload systems, we have developed the ability to anticipate challenges and avoid common pitfalls. The ADC linker-payload components are complex structures that are difficult to crystallize and require specialized high-potent handling. Veranova’s differentiated combination of world-leading crystallization development capabilities, complex synthesis experience, chromatography expertise and high-potent-handling experience put us in a unique position to solve these challenges for customers and speed their products to the clinic. We prioritize getting it right the first time, minimizing change orders and ensuring high-quality results. We have developed a robust phase-appropriate strategy that is backed by state-of-the-art analytical equipment and regulatory procedures to ensure our partners can rapidly progress their ADC projects from pre-clinical to commercialization. 🔑 HIGHLIGHTS// unlocking the life-changing potential of ADCs / ensuring our partners can rapidly progress their ADC projects Can you specify how Veranova is using artificial intelligence (AI) to optimize manufacturing processes that can reduce costs and environmental footprint as well as speed up development? In May 2024, Veranova announced a partnership with Phorum.AI to leverage AI to optimize pharmaceutical manufacturing processes. This collaboration aims to enable the rapid development of processes that can drive efficiency and reduce costs while maximizing environmental sustainability. Our goal is to combine Veranova’s extensive empirical manufacturing dataset of owned APIs and drug master files with Phorum.AI’s computational chemistry engine in order to create a more powerful process-development tool for the benefit of Veranova’s and Phorum’s customers. At Veranova, we are constantly looking to employ innovative technologies and approaches to improve efficiency, accelerate time to market and reduce environmental footprint. We have the means to work with a variety of partners who have unique project requirements, without sacrificing time to market.  🔑 HIGHLIGHTS// partnership with Phorum.AI / create a more powerful process-development tool / improve efficiency, accelerate time to market and reduce environmental footprint

Impressions: 1659

https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market

#SpeakPharma With Veranova
10 Sep 2024

VLOG #PharmaReel

[Sponsored by another company]

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination
The pharmaceutical industry has long recognized the critical role excipients or inactive ingredients play in drug formulation and delivery. Excipients can comprise up to 90 percent of a medicine's total ingredients and serve crucial functions as binders, disintegrants, coatings, preservatives, colors, and flavorings. According to recent market research, the pharmaceutical excipients market was valued at US$ 9.27 billion in 2023. It is growing at a compound annual growth rate (CAGR) of 7.03 percent and is projected to reach US$ 18.48 billion by 2032. The main factors driving market growth is an increased demand for multifunctional excipients, coupled with the expanding use of generic medications. The development in the biologics sector and advancements in nanotechnology are also contributing significantly to market growth. Major excipient providers include BASF, Evonik, Merck KGaA owned MilliporeSigma, Gangwal Healthcare, Roquette Frères, DuPont, Croda International, Seqens, Boai NKY Pharmaceuticals, PMC Isochem, Minakem, Kewpie Corporation, Ashland Global, SPI Pharma, Pfanstiehl, Nanjing Well Pharmaceutical, ICE Pharma, Anhui Ribobay Pharmaceutical and Nippon Fine Chemical.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) WHO, India’s CDSCO tighten regulations; new GMP guidelines implemented to curb contamination Last year, the World Health Organization (WHO) issued a health alert linking at least 300 child deaths in the Gambia, Uzbekistan, and Indonesia to the ingestion of contaminated cough syrups containing unacceptable levels of diethylene glycol (DEG) and ethylene glycol (EG). In response to the tragic events, the WHO released two draft appendices to its guideline on good manufacturing practices (GMPs) for excipients this year. Manufacturers are now required to use suitable risk assessment tools to identify and mitigate potential hazards.  Since India-made cough syrups had been linked to the deaths, India’s drug regulator — Central Drugs Standard Control Organization (CDSCO) — took steps to prevent contamination, and advised drugmakers to only use pharmaceutical-grade excipients from approved sources. Furthermore, the Indian Health Ministry proposed amendments to the Drugs and Cosmetics Rules, 1945 to include details of excipients on drug labels. While listing all excipients on every strip of medicine may be challenging, the ministry suggested mentioning those causing hypersensitivity on the label. Applicants now mandatorily need to submit evidence of stability and safety of excipients. These regulatory developments have significant implications for excipient manufacturers and pharmaceutical companies worldwide. Leading pharmaceutical excipient firms like Gangwal Healthcare, Sigachi Industries, and Nitika Pharmaceuticals are well-positioned to meet these heightened quality and safety standards, given their long-standing commitment to producing high-quality, compliant excipients.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Roquette buys IFF’s pharma unit for US$ 2.85 bn; Evonik opens new spray-drying facility in Darmstadt In a significant industry move, France-based Roquette entered into an agreement to acquire IFF's pharma solutions business in a deal valued at US$ 2.85 billion. This acquisition is set to rebalance family-owned Roquette’s portfolio around health and nutrition. The deal is expected to accelerate Roquette’s growth and significantly strengthen its presence in the excipients market. Evonik has opened a new facility for drying aqueous dispersions of its Eudragit polymers at its site in Darmstadt, Germany. The facility will help Evonik meet increasing demand from drugmakers for its oral drug delivery solutions. The plant uses green energy solutions. The company has also partnered University of Mainz to commercialize a new class of polyethylene glycols (PEG) lipids for nucleic acid delivery. Evonik’s Health Care business has been growing its nucleic acid drug and vaccine delivery portfolio.  Germany’s Johannes Gutenberg University of Mainz was the first to develop randomized polyethylene glycols (rPEGs). This collaboration aims to expand Evonik’s toolbox of technologies for nucleic acid-based medicines, offering an improved immunogenicity profile for lipid nanoparticle carriers used in mRNA vaccines and therapeutics. Asahi Kasei made significant strides in addressing a pressing industry concern that emerged in 2018 when potentially carcinogenic nitrosamine impurities were detected in several pharmaceuticals. Guided by regional authorities, such as the European Medicines Agency and the US Food and Drug Administration, the pharmaceutical industry has been carrying out extensive assessments and research to identify the cause of these impurities. In response to this challenge, Asahi Kasei developed its Ceolus microcrystalline cellulose with extremely low nitrite levels. The Japanese company achieved nitrite concentrations of 0.1 micrograms per gram or less, which is equivalent to 0.1 parts per million (ppm). The company also started full commercial operation of its second manufacturing facility for Ceolus in Japan, enhancing supply capacity and stability. JRS Pharma and Gujarat Microwax opened a state-of-the-art cotton-based croscarmellose sodium plant in Mehsana, Gujarat (India). This facility aims to produce high-quality excipients that meet global standards, potentially reducing India's dependency on imports and boosting its presence in the global excipient market. The Indian excipient industry accounts for less than 1 percent of the global market share.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Seqens to advance innovative polymer; biologics, personalized medicine create demand for specialized excipients Recent industry collaborations highlight the ongoing innovation in novel excipients. France’s Seqens, with over 20 years of polymer development experience, was chosen by Pleryon Therapeutics to advance its leading osteoarthritis candidate – an innovative GMP polymer. This collaboration leverages Seqens’ newly expanded and modernized cGMP plant in Aramon, France, demonstrating the industry’s commitment to investing in advanced manufacturing capabilities for novel excipients.  The rise of biologics and personalized medicine has created a demand for specialized excipients capable of stabilizing complex molecules and enabling targeted drug delivery. Roquette’s launch of Lycagel Flex, a hydroxypropyl pemix for nutraceutical and pharmaceutical softgel capsules, exemplifies this trend. Built on Roquette’s market-first Lycagel pea starch technology, this plant-based alternative to gelatin offers manufacturers the flexibility to customize formulations for a range of production and end-user needs. The innovative pea starch foundation also underscores the industry’s move towards sustainable bio-based excipients. The trend towards patient-centric drug development has also influenced excipient innovation. Excipients that can improve palatability, ease of swallowing, or enable novel dosage forms (such as orally disintegrating tablets) are in high demand. For example, IFF brought a super disintegrant Ac-Di-Sol, that supports faster disintegration and drug dissolution in oral disintegrating tablets, improving patient experience.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Our view The heightened regulatory scrutiny on excipients due to product contamination incidents has created a high risk perception and uncertainty around the regulatory acceptance of novel excipients. That said, novel excipients are central to the development of new drug modalities and therapies. Going forward, sustainability will also become an increasingly important factor in excipient selection and development. As the industry innovates towards biologics, personalized therapies, and patient-centric formulations, the role of high-quality, multifunctional excipients will only grow more vital in ensuring drug stability, bioavailability, and patient compliance. Companies that can navigate the complex regulatory landscape, invest in R&D, and offer high-quality, multifunctional excipients will be well-positioned to succeed in this evolving market.   

Impressions: 727

https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination

#PharmaFlow by PHARMACOMPASS
12 Sep 2024

NEWS #PharmaBuzz

read-more
read-more
Bio X Cell Appoints Christopher Conway CEO
Bio X Cell Appoints Christopher Conway CEO

12 Aug 2024

// CONTRACT PHARMA

https://www.contractpharma.com/contents/view_breaking-news/2024-08-12/bio-x-cell-appoints-christopher-conway-ceo/72644

CONTRACT PHARMA
12 Aug 2024
Siegfried expands US reach with deal for Wisconsin facility
Siegfried expands US reach with deal for Wisconsin facility

13 Jun 2024

// Joseph Keenan FIERCE PHARMA

https://www.fiercepharma.com/manufacturing/cdmo-siegfried-expands-us-footprint-acquisition-wisconsin-facility

Joseph Keenan FIERCE PHARMA
13 Jun 2024

https://www.globenewswire.com/news-release/2024/05/09/2878810/0/en/Curia-and-Carterra-Partner-on-Biologics-Symposium-to-Further-Biotechnology-Research-in-the-Pacific-Northwest.html

GLOBENEWSWIRE
09 May 2024

https://curiaglobal.com/news/curia-and-carterra-partner-on-biologics-symposium-to-further-biotechnology-research-in-the-pacific-northwest/

PRESS RELEASE
09 May 2024

https://curiaglobal.com/news/curia-appoints-steve-lavezoli-as-vice-president-biologics/

PRESS RELEASE
23 Feb 2024
Curia Receives 2024 CDMO Leadership Award
Curia Receives 2024 CDMO Leadership Award

05 Feb 2024

// PRESS RELEASE

https://curiaglobal.com/news/curia-receives-2024-cdmo-leadership-award/

PRESS RELEASE
05 Feb 2024

Services

Upload your portfolio for free, ask us

Analytical

Click here to discover the service providers for Analytical

API Manufacturing

Click here to discover the service providers for API Manufacturing

Drug Product Manufacturing

Click here to discover the service providers for Drug Product Manufacturing

API & Drug Product Development

Click here to discover the service providers for API & Drug Product Development

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

Excipients by Ingredients

Upload your portfolio for free, ask us

Excipients By applications

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Curia and get a quotation

Curia is a supplier offers 168 products (APIs, Excipients or Intermediates).

Find a price of Betamethasone Dipropionate bulk with DMF, CEP, JDMF offered by Curia

Find a price of Betamethasone Sodium Phosphate bulk with DMF, CEP, JDMF offered by Curia

Find a price of Clobetasol Propionate bulk with DMF, CEP, JDMF offered by Curia

Find a price of Cyclosporine bulk with DMF, CEP, JDMF offered by Curia

Find a price of Dorzolamide Hydrochloride bulk with DMF, CEP, JDMF offered by Curia

Find a price of Hydrocortisone bulk with DMF, CEP, JDMF offered by Curia

Find a price of Minocycline Hydrochloride bulk with DMF, CEP, JDMF offered by Curia

Find a price of Propofol bulk with DMF, CEP, JDMF offered by Curia

Find a price of Alclometasone Dipropionate bulk with DMF, JDMF offered by Curia

Find a price of Betamethasone Valerate bulk with CEP, JDMF offered by Curia

Find a price of Brimonidine Tartrate bulk with DMF, CEP offered by Curia

Find a price of Bromocriptine Mesylate bulk with DMF, CEP offered by Curia

Find a price of Budesonide bulk with DMF, CEP offered by Curia

Find a price of Chlorthalidone bulk with DMF, CEP offered by Curia

Find a price of Desogestrel bulk with DMF, CEP offered by Curia

Find a price of Dexamethasone bulk with CEP, JDMF offered by Curia

Find a price of Dexamethasone Sodium Phosphate bulk with DMF, CEP offered by Curia

Find a price of Dihydroergotamine Mesylate bulk with DMF, CEP offered by Curia

Find a price of Ergotamine Tartrate bulk with DMF, CEP offered by Curia

Find a price of Exemestane bulk with DMF, CEP offered by Curia

Find a price of Fentanyl bulk with DMF, CEP offered by Curia

Find a price of Fentanyl Citrate bulk with DMF, CEP offered by Curia

Find a price of Flutamide bulk with DMF, CEP offered by Curia

Find a price of Fluticasone Propionate bulk with DMF, CEP offered by Curia

Find a price of Furosemide bulk with DMF, CEP offered by Curia

Find a price of Hydrocortisone Butyrate bulk with DMF, JDMF offered by Curia

Find a price of Mifepristone bulk with DMF, JDMF offered by Curia

Find a price of Mometasone Furoate bulk with DMF, CEP offered by Curia

Find a price of Olopatadine Hydrochloride bulk with DMF, JDMF offered by Curia

Find a price of Pancuronium Bromide bulk with DMF, CEP offered by Curia

Find a price of Pramipexole Dihydrochloride bulk with DMF, CEP offered by Curia

Find a price of Prednisolone Sodium Phosphate bulk with DMF, JDMF offered by Curia

Find a price of Ribavirin bulk with DMF, CEP offered by Curia

Find a price of Rocuronium Bromide bulk with DMF, CEP offered by Curia

Find a price of Testosterone bulk with DMF, CEP offered by Curia

Find a price of Triamcinolone Acetonide bulk with DMF, JDMF offered by Curia

Find a price of Ulipristal Acetate bulk with DMF, JDMF offered by Curia

Find a price of Vecuronium Bromide bulk with DMF, JDMF offered by Curia

Find a price of Alcaftadine bulk with DMF offered by Curia

Find a price of Altrenogest bulk with DMF offered by Curia

Find a price of Amphetamine bulk with DMF offered by Curia

Find a price of Amphetamine Aspartate bulk with DMF offered by Curia

Find a price of Argatroban bulk with DMF offered by Curia

Find a price of Atropine Sulfate bulk with DMF offered by Curia

Find a price of Azelastine Hydrochloride bulk with DMF offered by Curia

Find a price of Aztreonam bulk with DMF offered by Curia

Find a price of Beclomethasone Dipropionate bulk with CEP offered by Curia

Find a price of Benztropine bulk with DMF offered by Curia

Find a price of Betamethasone Butyrate Propionate bulk with JDMF offered by Curia

Find a price of Betamethasone Sodium Phosphate bulk with CEP offered by Curia

Find a price of Brexanolone bulk with DMF offered by Curia

Find a price of Butabarbital bulk with DMF offered by Curia

Find a price of Butorphanol Tartrate bulk with DMF offered by Curia

Find a price of Cannabidiol bulk with DMF offered by Curia

Find a price of Carbimazole bulk with CEP offered by Curia

Find a price of CAS 71-58-9 bulk with CEP offered by Curia

Find a price of Choline Fenofibrate bulk with DMF offered by Curia

Find a price of Cifenline bulk with JDMF offered by Curia

Find a price of Clascoterone bulk with DMF offered by Curia

Find a price of Cyclofenil bulk with JDMF offered by Curia

Find a price of Cyclosporine bulk with DMF offered by Curia

Find a price of Cyproterone Acetate bulk with CEP offered by Curia

Find a price of Deoxycholic Acid bulk with DMF offered by Curia

Find a price of Dexamethasone Dipropionate bulk with JDMF offered by Curia

Find a price of Dexamethasone Valerate bulk with JDMF offered by Curia

Find a price of Dexmethylphenidate bulk with DMF offered by Curia

Find a price of Dextroamphetamine Saccharate bulk with DMF offered by Curia

Find a price of Diatrizoate Meglumine bulk with DMF offered by Curia

Find a price of Diatrizoate Sodium bulk with DMF offered by Curia

Find a price of Dihydroergocristine bulk with CEP offered by Curia

Find a price of Dihydroergotoxine Mesylate bulk with DMF offered by Curia

Find a price of Dihydrolysergic Acid Amide bulk with DMF offered by Curia

Find a price of Drospirenone bulk with CEP offered by Curia

Find a price of Echothiophate Iodide bulk with DMF offered by Curia

Find a price of Epinephrine bulk with DMF offered by Curia

Find a price of Ethanolamine Oleate bulk with DMF offered by Curia

Find a price of Etonogestrel bulk with DMF offered by Curia

Find a price of Finasteride bulk with CEP offered by Curia

Find a price of Fludrocortisone Acetate bulk with DMF offered by Curia

Find a price of Fluorometholone bulk with DMF offered by Curia

Find a price of Fluoxymesterone bulk with DMF offered by Curia

Find a price of Hexetidine bulk with CEP offered by Curia

Find a price of Homoharringtonine bulk with DMF offered by Curia

Find a price of Hydrochloric Acid bulk with DMF offered by Curia

Find a price of Hydrocortisone bulk with DMF offered by Curia

Find a price of Hydrocortisone Acetate bulk with CEP offered by Curia

Find a price of Hydrocortisone Sodium Succinate bulk with CEP offered by Curia

Find a price of Hydroxychloroquine Sulphate bulk with DMF offered by Curia

Find a price of Isosorbide Mononitrate bulk with CEP offered by Curia

Find a price of L-Tartaric Acid bulk with DMF offered by Curia

Find a price of Lacosamide bulk with DMF offered by Curia

Find a price of Levocabastine bulk with CEP offered by Curia

Find a price of Loteprednol Etabonate bulk with DMF offered by Curia

Find a price of Mac321 bulk with DMF offered by Curia

Find a price of Mafenide bulk with DMF offered by Curia

Find a price of Mecamylamine bulk with DMF offered by Curia

Find a price of Mecamylamine Hydrochloride bulk with DMF offered by Curia

Find a price of Medroxyprogesterone Acetate bulk with DMF offered by Curia

Find a price of Methylphenidate Hydrochloride bulk with DMF offered by Curia

Find a price of Methylprednisolone Acetate bulk with DMF offered by Curia

Find a price of Metolazone bulk with DMF offered by Curia

Find a price of Milrinone bulk with JDMF offered by Curia

Find a price of Minocycline Hydrochloride bulk with DMF offered by Curia

Find a price of Monomethyl Fumarate bulk with DMF offered by Curia

Find a price of Mycophenolate Sodium bulk with DMF offered by Curia

Find a price of Naltrexone Methobromide bulk with DMF offered by Curia

Find a price of Nepafenac bulk with DMF offered by Curia

Find a price of Niflumic Acid bulk with CEP offered by Curia

Find a price of Norepinephrine Bitartrate bulk with DMF offered by Curia

Find a price of Olopatadine Hydrochloride bulk with DMF offered by Curia

Find a price of Oxandrolone bulk with DMF offered by Curia

Find a price of Pentetic Acid bulk with DMF offered by Curia

Find a price of Pentobarbital Sodium bulk with DMF offered by Curia

Find a price of Pethidine Hydrochloride bulk with DMF offered by Curia

Find a price of Pimecrolimus bulk with DMF offered by Curia

Find a price of Pralidoxime Chloride bulk with DMF offered by Curia

Find a price of Prednisone bulk with DMF offered by Curia

Find a price of Pyrazole Diamide, 29 bulk with DMF offered by Curia

Find a price of Regadenoson Monohydrate bulk with DMF offered by Curia

Find a price of Riboflavin 5 Phosphate Sodium bulk with DMF offered by Curia

Find a price of Ritalinic Acid bulk with DMF offered by Curia

Find a price of Ritonavir bulk with DMF offered by Curia

Find a price of Segesterone Acetate bulk with DMF offered by Curia

Find a price of Sirolimus bulk with DMF offered by Curia

Find a price of Sodium Oxybate bulk with DMF offered by Curia

Find a price of Succinate bulk with DMF offered by Curia

Find a price of Tapentadol bulk with DMF offered by Curia

Find a price of Testosterone Cypionate bulk with DMF offered by Curia

Find a price of Tetrahydrocannabinol bulk with DMF offered by Curia

Find a price of Thiazole bulk with DMF offered by Curia

Find a price of Ticlopidine bulk with DMF offered by Curia

Find a price of Travoprost bulk with DMF offered by Curia

Find a price of Triamcinolone Acetonide bulk with JDMF offered by Curia

Find a price of Trientine Hydrochloride bulk with DMF offered by Curia

Find a price of Upadacitinib bulk with DMF offered by Curia

Find a price of Viloxazine Hydrochloride bulk with DMF offered by Curia

Find a price of Vorinostat bulk with DMF offered by Curia

Find a price of Voxelotor bulk with DMF offered by Curia

Find a price of KETOENAMINE bulk with DMF offered by Curia

Find a price of EBAB bulk with DMF offered by Curia

Find a price of INTERMEDIATE PERG/9 D-6-N-(PROPIONYL)-8BETA-METHYLTHIOMETHYLERGOLINE bulk with DMF offered by Curia

Find a price of Aripiprazole bulk offered by Curia

Find a price of Bamifylline bulk offered by Curia

Find a price of Betamethasone bulk offered by Curia

Find a price of Betamethasone Acetate bulk offered by Curia

Find a price of Betamethasone Benzoate bulk offered by Curia

Find a price of Deflazacort bulk offered by Curia

Find a price of Deucravacitinib bulk offered by Curia

Find a price of Diethylamine Salicylate bulk offered by Curia

Find a price of Dihydroergocryptine bulk offered by Curia

Find a price of Etrasimod bulk offered by Curia

Find a price of Flurogestone Acetate bulk offered by Curia

Find a price of Ganaxolone bulk offered by Curia

Find a price of Hydroxyethyl Salicylate bulk offered by Curia

Find a price of Medrogestone bulk offered by Curia

Find a price of Melengestrol Acetate bulk offered by Curia

Find a price of Methylprednisolone Aceponate bulk offered by Curia

Find a price of Methylprednisolone Hemisuccinate bulk offered by Curia

Find a price of Methylprednisolone Sodium Succinate bulk offered by Curia

Find a price of Morniflumate bulk offered by Curia

Find a price of Nifuratel bulk offered by Curia

Find a price of Paliperidone Palmitate bulk offered by Curia

Find a price of Prednicarbate bulk offered by Curia

Find a price of Propacetamol HCl bulk offered by Curia

Find a price of Samidorphan L-Malate bulk offered by Curia

Find a price of Tamsulosin bulk offered by Curia

Find a price of Testosterone Propionate bulk offered by Curia

Find a price of Zuranolone bulk offered by Curia

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty